Immunoglobulin G heavy-chain allotypes as possible genetic markers for human cancer. 1981

Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji

Serum samples from 343 unrelated, healthy Japanese, 194 hepatitis B surface antigen (HBsAg)-positive healthy carriers, 96 patients with primary hepatoma, 91 patients with lung cancer, 94 patients with breast cancer, and 87 patients with gastric cancer were examined for IgG heavy-chain allotypes (Gm). The Gm phenotypes of the sera from patients with breast cancer exhibited a distribution similar to that of the normal controls. However, compared to that of normal controls, the Gm phenotype (1,2,21,13,15,16) was significantly increased in the patients with primary hepatoma(chi 2 (1) = 15.12, corrected P less than 0.01) and in the patients with lung cancer (chi 2 (1) = 10.97, corrected P less than 0.05). Compared to that of normal controls, the haplotype Gm 1,2,21 was significantly increased in the patients with primary hepatoma (chi 2 (1) = 22.34, corrected P less than 0.01). Increased frequency of Gm 1,2,21 in primary hepatoma was also significant compared to that of HBsAg-positive healthy carriers (chi 2 (1) = 9.25, corrected P less than 0.05).

UI MeSH Term Description Entries
D007126 Immunoglobulin Allotypes Allelic variants of the immunoglobulin light chains (IMMUNOGLOBULIN LIGHT CHAINS) or heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) encoded by ALLELES of IMMUNOGLOBULIN GENES. Allotypes, Immunoglobulin,Allotypic Antibodies,Antibodies, Allotypic,Ig Allotypes,Allotype, Ig,Allotype, Immunoglobulin,Allotypes, Ig,Allotypic Antibody,Antibody, Allotypic,Ig Allotype,Immunoglobulin Allotype
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
June 1981, The Journal of clinical investigation,
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
January 2009, mAbs,
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
November 1983, Gastroenterology,
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
July 1983, The Journal of clinical investigation,
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
November 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
April 1999, Scandinavian journal of immunology,
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
December 2002, Immunological reviews,
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
February 1975, Maroc medical,
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
August 1989, The Journal of biological chemistry,
Y Nakao, and H Matsumoto, and T Miyazaki, and S Watanabe, and T Mukojima, and R Kawashima, and T Fujita, and K Tsuji
December 1971, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!